08~10 Nov, 2022: Samuel JK Abraham, Yamanashi, Japan., Beneficial balancing of amino-acids through gut-microbiome modulation using two unique variants of beta
glucans in Non-alcoholic steatohepatitis (NASH) animal model
08~10 Nov, 2022: Samuel JK Abraham, Yamanashi, Japan., Regulation of dysbiosis and increase in abundance of beneficial gut microbiota by biological response
modifier glucan in a clinical study in Duchenne Muscular Dystrophy
23~25, Sep, 2022: Preethy et al., A two-step strategy to manage hypoxic ischemic encephalopathy by tackling acute and chronic phases with two novel variants of unique biological response modifier glucans. "5th Annual Conference of the Society of Neurocritical care (SNCC)"